StockNews.com Begins Coverage on Sorrento Therapeutics (NASDAQ:SRNE)
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ:SRNE opened at $0.08 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.79 and a debt-to-equity […]
More Stories
Democrats Wrestle With DOGE and Musk
By Nathan Worcester WASHINGTON—During the first two months of the second Trump administration, few issues have united Democrats like opposition...
Tom Cruise, 62, and Ana de Armas, 36, Spotted Together Again in London
Hollywood stars Tom Cruise and Ana de Armas have once again been spotted together in London, fueling further speculation about...
Proficio Capital Partners LLC Takes $7.35 Million Position in Reliance, Inc. (NYSE:RS)
Proficio Capital Partners LLC purchased a new stake in Reliance, Inc. (NYSE:RS – Free Report) during the fourth quarter, according...
Zurcher Kantonalbank Zurich Cantonalbank Buys 2,969 Shares of TD SYNNEX Co. (NYSE:SNX)
Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of TD SYNNEX Co. (NYSE:SNX – Free Report) by 18.6% in...
Zurcher Kantonalbank Zurich Cantonalbank Buys 2,969 Shares of TD SYNNEX Co. (NYSE:SNX)
Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of TD SYNNEX Co. (NYSE:SNX – Free Report) by 18.6% in...
Independent Advisor Alliance Buys 194 Shares of Equinix, Inc. (NASDAQ:EQIX)
Independent Advisor Alliance increased its position in shares of Equinix, Inc. (NASDAQ:EQIX – Free Report) by 45.8% in the fourth...